Advances in contraceptive vaginal rings: what does the future hold?
- 5 October 2018
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Opinion on Pharmacotherapy
- Vol. 19 (15), 1685-1691
- https://doi.org/10.1080/14656566.2018.1519549
Abstract
Introduction: Contraceptive vaginal rings (CVRs) are good contraceptive options because they do not require skilled providers, are self-administered, and show a higher stability of drug diffusion.Area covered: This article provides a review of the developments made with CVRs over the past number of years, while giving focus to the latest CVRs that have gone through clinical development. The author of the article also provides an expert perspective on the future of these useful therapeutic options.Expert opinion: Pharmacokinetic studies have shown that segesterone, an absorbable progestin that is used alone or in combination with ethinyl estradiol (EE) or E-2,E- is the CVR of choice at this present time. Indeed, segesterone has demonstrated safety and efficacy as a CVR and is also an appropriate option for lactating women, as they are not absorbed orally. However, good cycle control is important for improved CVR adherence. CVRs that allow the combination of more than one drug may unravel another multi-purpose use when combined with microbicides and could provide combined protection to women who wish to protect themselves from pregnancy and sexually transmitted infection.Keywords
Funding Information
- not funded
This publication has 66 references indexed in Scilit:
- Effects of a novel estrogen-free, progesterone receptor modulator contraceptive vaginal ring on inhibition of ovulation, bleeding patterns and endometrium in normal womenContraception, 2012
- Risk of venous thromboembolism among users of oral contraceptives: a review of two recently published studiesBMJ Sexual & Reproductive Health, 2010
- Sustained release of microbicides by newly engineered vaginal ringsAIDS, 2009
- Frequency and Management of Breakthrough Bleeding With Continuous Use of the Transvaginal Contraceptive RingObstetrics & Gynecology, 2008
- Extended Regimens of the Contraceptive Vaginal RingObstetrics & Gynecology, 2005
- New delivery systems in contraception: vaginal ringsAmerican Journal of Obstetrics and Gynecology, 2004
- Progestin-only contraceptive ringsSteroids, 2000
- Pharmacokinetics of Etonogestrel and Ethinylestradiol Released from a Combined Contraceptive Vaginal RingClinical Pharmacokinetics, 2000
- Design of an intravaginal ring for the controlled delivery of 17β-estradiol as its 3-acetate esterJournal of Controlled Release, 1999
- Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control studyThe Lancet, 1995